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The lack of social contacts may be an important element in the presumed vicious circle aggravating, or at
least stabilising negative symptoms in patients with schizophrenia. A European 2-year cohort study
collected negative symptom scores, psychosocial functioning scores, objective social contact frequency
scores and quality of life scores every 6 months. Bivariate analyses, correlation analyses, multivariate
regressions and random effects regressions were conducted to describe relations between social contact
and outcomes of interest and to gain a better understanding of this relation over time. Using data from
1208 patients with schizophrenia, a link between social contact frequency and negative symptom scores,
functioning and quality of life at baseline was established. Regression models conﬁrmed the signiﬁcant
association between social contact and negative symptoms as well as psychosocial functioning. This
study aimed at demonstrating the importance of social contact for deﬁcient behavioural aspects of
schizophrenia.
& 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Schizophrenia is a multidimensional disorder that prevents
people from having a normal social life. Integration in the labour
market is rare; participation in social networks is low as is psy-
chosocial functioning (Fleury et al., 2013). There is evidence that
social deﬁcits are closely related to negative symptoms of schi-
zophrenia and both may lead to reduced quality of life (Breier
et al., 1991; Fenton and McGlashan, 1991; Katschnig, 2000; Nor-
man et al., 2000). Low frequency of social contacts is one aspect of
low participation in social networks; and this, combined with
negative symptoms, may be an important therapeutic domain
(Kirkpatrick et al., 2006). Different dimensions of the disorder and
emotional/social concomitants form a complex network of inter-
related factors. Some of these converge in impaired role function
performance. Patients with schizophrenia ﬁnd themselves caught
in a vicious circle, as all the elements of the disease reinforce each
other. Low frequency of social contacts is similar to the negative
symptom “social withdrawal”, yet it has a different focus. WhereasIreland Ltd. This is an open acces
Siegrist),
utical.com (I. Amri),
i@emaud.org (M. Toumi).“social withdrawal” relies upon different aspects of social in-
tegration as estimated by the interviewer, frequency of social
contact items ask the patient for facts concerning contact only.
Solely based on rare social contact, the process of social con-
struction of reality (Berger and Luckmann, 1966) – necessary to
share concepts of reality with other people – is disturbed. Patients'
concepts of reality become more and more idiosyncratic as they
grow farther apart from other people's interpretations of the
world. More social contact would imply more chance of develop-
ing socially shared concepts of reality (Fig. 1).
Poor social contact implies poor emotional exchange. Socio-
emotional functioning, one aspect of psychosocial functioning re-
quires emotional exchange. In patients with schizophrenia, deﬁcits
in social interaction are related to problems in the domain of
handling emotions as communicative signals (Csukly et al., 2013).
More social contact would train the ability of interpreting other
people's emotions. This would be a step toward less emotional
withdrawal.
Although several studies have assessed the relationship be-
tween psychotic symptoms and functioning or quality of life
(Smith et al., 2002; Rocca et al., 2009; Weinberg et al., 2009; Brüne
et al., 2011; Corcoran et al., 2011), little information is available on
the role of social contact in this area. Since the elements are in-
terrelated in a multidirectional way it is important the make thes article under the CC BY-NC-ND license
Fig. 1. Presumed vicious circle.
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The starting point of this analysis is the key role of negative
symptoms in the course of the disease, their chronicity and their
relation to poor functional outcome and poor quality of life. The
research question was deﬁned as follows: “is social contact an
element in the presumed vicious circle, associated with more
negative symptoms and particularly more emotional withdrawal,
and with deterioration of psychosocial functioning and quality of
life?” As there is no real therapeutic option today (Buchanan,
2007; Kring et al., 2013), it would be important to identify a means
toward reintegration of patients with schizophrenia and im-
provement of their socio-emotional functioning. Reinforcement of
social contact may be considered as such, if lack of (or very low
frequency of) social contact is shown to predict aggravation of
negative symptoms.
The objective of this study is to describe the pre-supposed as-
sociation between social contact frequency and negative symp-
toms, particularly emotional withdrawal, as well as with psycho-
social functioning and subjective quality of life. It was deemed
crucial to evaluate both cross-sectional and longitudinal associa-
tions between these elements. As anxiety and depression – two
symptoms often accompanying schizophrenic disorders – are also
related to poor psychosocial functioning and poor quality of life,
they should be controlled (Katschnig, 2000; Buchanan, 2007).2. Methods
2.1. Data source
EuroSC is a naturalistic follow-up of a cohort of people with schizophrenia over
a period of two years, with ﬁve visits at 6-month intervals. A detailed description of
the cohort was published earlier (Bebbington et al., 2005). The principle objective
of this cohort was to identify and describe the types of treatment and methods of
care for people with schizophrenia and to correlate these with clinical outcomes,
states of health, and quality of life. The subjects were selected to provide a re-
presentative sample of patients treated in each catchment area. The centres and
sampling procedures were chosen to suit the national organisation of mental
health care and the information systems that could be exploited for the study. In
France, the selected locations included northern France (Lille), central France (Lyonand Clermont-Ferrand), and southern France (Marseille and Toulon). Each of these
areas covers an urban centre of approximately 1 million inhabitants living in the
city or in medium-size towns. The study in Germany was carried out in four
catchment areas: Leipzig and Altenburg in former East Germany, and Hemer and
the County of Heilbronn in former West Germany. In the UK, the selected locations
included two centres, Islington, a socially deprived inner-city area of London, and a
reasonably afﬂuent semi-rural area of Leicestershire. For each country, the speciﬁc
locations were chosen because they are socio-demographically distinct and have
different styles of service delivery. In each centre, a cohort of patients with schi-
zophrenia and in contact with secondary psychiatric services was identiﬁed and
assessed. One thousand two hundred and eight patients with schizophrenia were
included in the study, 288 in France, 618 in Germany, and 302 in the UK. Where
possible, random sampling was used (all the French centres and in London),
otherwise the exhaustive inclusion approach was used. This involved the deﬁnition
of a smaller catchment area, with the aim of including all patients with schizo-
phrenia in the area. All mental health services in the area were contacted in order
to identify patients previously or currently treated by them. Patients were screened
to establish informed consent, and whether they met the inclusion/exclusion
criteria.
This project was conducted in accordance with the Declaration of Helsinki
(WMA, 2008). Subjects were aged between 18 and 64 years at the time of enrol-
ment in the study, had a diagnosis of schizophrenia according to DSM IV criteria
(APA (American Psychiatric Association), 1994), and had provided a signed in-
formed consent.
2.2. Data collection
After consent was obtained, patients were interviewed by a trained in-
dependent psychiatrist, and the initial battery of assessments was completed. The
data collected included socio-demographic information, and clinical information.
Socio-demographic information included country, gender, age, length of illness,
family situation and diagnosis. All were collected at the baseline visit. Clinical in-
formation included the Positive and Negative Symptoms Scale (PANSS) (Kay et al.,
1989; Bell et al., 1992), the Calgary Depression Scale for Schizophrenia (CDSS)
(Addington et al., 1990), the Global Assessment of Functioning (GAF) (Endicott et al.,
1976) and the Quality of Life Interview (QoLI) (Lehman, 1983). All these measures
were collected at each visit by the interviewer.
The PANSS evaluates the level of psychiatric symptoms in patients with schi-
zophrenia. Several subscores of interest in this study were used, including item N2
(relative to emotional withdrawal), item G2 (relative to anxiety), the negative factor
(as mean of items N1, N2, N3, N4, N6, G7 and G16) and the negative subscore (as
mean of items N1, N2, N3, N4, N5, N6 and N7) (Kay et al., 1989). The negative
subscore includes cognitive aspects (deﬁcits in abstract thinking and stereotyped
thinking) which the factor leaves out, and instead includes motor retardation and
active social avoidance. The item N4, estimating social withdrawal, takes into ac-
count behavioural aspects of social integration inferred from other data assessed
Table 1
Demographic and main clinical characteristics at baseline (N¼1208).
Variable Result (N¼1208)
Country Missing values 0
Germany (N, %) 618 (51.1%)
France (N, %) 288 (23.8%)
UK (N, %) 302 (29.4%)
Gender Missing values 6
Male (N, %) 743 (61.8%)
Female (N, %) 459 (38.2%)
Age Missing values 2
Mean (SD) 41.0 (10.9)
Length of illness Missing values 0
Mean (SD) 13.7 (10.3)
Family situation (N, %) Missing values 1
Single (N, %) 744 (61.6%)
Married (N, %) 181 (15.0%)
Living as a couple (N, %) 73 (6.1%)
Divorced/separated (N, %) 195 (16.2%)
Widowed (N, %) 14 (1.2%)
Diagnosis (N, %) Missing values 54
Disorganised (N, %) 69 (5.98%)
Catatonic (N, %) 17 (1.47%)
Paranoid (N, %) 871 (75.48%)
Undifferentiated (N, %) 87 (7.54%)
Residual (N, %) 110 (9.53%)
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All items and subscores ranged from 1 to 7, with higher scores indicating more
severe states.
The CDSS evaluates the level of depression in patients with schizophrenia. It
consists of 9 items, and ranges from 0 to 27, with higher scores indicating more
severe states.
The GAF evaluates the psychological, social, and occupational functioning. It
ranges from 0 to 100, with higher scores indicating higher functioning level. “Socio-
emotional competence”, would have been an interesting element of “psychosocial
functioning”, but this was not measured directly. However, it is possible to relate
GAF and emotional withdrawal to frequency of social contact, which was con-
sidered a necessary condition of normal social interaction.
The QoLI-brief version (Lehman, 1983), which is a patient-reported outcome
questionnaire, assesses the quality of life of persons with chronic mental disorders,
depending on both what they actually do and experience (“objective” quality of
life) and their feelings about these experiences (“subjective” quality of life). The
Global Life Satisfaction (GLS) is a subjective indicator of quality of life derived for
the QoLI, and ranges from 0 to 7, higher values indicating a better quality of life.
Several subscores can be derived from QoLI, including the objective frequency of
social contact (OFSC) score. Information about basic facts of social life (people not
in the same family) is obtained by the interviewer, who notes the facts as presented
by the patient. Basic facts include visits (“about how often do you visit someone
who does not live with you?”), telephone (“about how often do you telephone
someone who does not live with you?”), organised activity (“about how often do
you do something with another person that you planned ahead of time?”) and
spending time with a partner (“about how often do you spend time with someone
you consider more than a friend, like a spouse, a boyfriend or a girlfriend?”), rated 1
(“not at all”), 2 (“less than once a month”), 3 (“at least once a month”), 4 (“at least
once a week”) or 5 (“at least once a day”). More details about the questionnaire
including as its reliability and validity are provided elsewhere (Lehman et al., 1993).
Medication (antipsychotics, antidepressants, etc.) was also collected at each
visit in UK and France. Nevertheless, the data was unobtainable in Germany.
Therefore it was decided not to include any medication parameter as a potential
confounder in the analysis.
If the participant withdrew consent at any time or if the participant was lost to
follow-up, data collected up to this point were used in analysis.
2.3. Statistical analysis
In this study, the outcomes of interest included emotional withdrawal (PANSS
N2 item, PANSS negative subscore and PANSS negative factor), functioning (GAF)and quality of life (GLS). All analyses where conducted using potential confounding
factors as controls, including country, age, gender, depression level (CDSS) and
anxiety level (G2).
First, descriptive analyses of socio-demographic variables were performed at
the baseline visit, while clinical characteristics were described at each visit.
Secondly, correlations between outcomes of interest and social contact fre-
quency (OFSC) were computed (Spearman correlations) using controls.
Thirdly, linear regression analysis was used to evaluate whether little social
contact (OFSC) at the baseline visit would result in either more emotional with-
drawal, negative symptoms (N2, negative subscore, negative factor), or less func-
tioning and quality of life after 2 years. The change from baseline for each outcome
of interest was modelled as a function of the associated baseline value, OFSC
baseline value and controls. The coefﬁcient for OFSC baseline value was checked for
signiﬁcance.
Finally, several generalised linear mixed models (random effects regression
analysis) were conducted, taking into account several assessments per patient.
These models enabled the test for a correlation in OFSC score and outcomes of
interest, controlling for repeated measures on the same subjects. In addition, age,
gender, depression level (CDSS) and anxiety level (G2) at relevant time point were
included in the model as potential confounding factors, and a random effect on
country was implemented. The coefﬁcient for OFSC value at the preceding visit was
checked for signiﬁcance.
All regression analyses were performed using SAS version 9.3.3. Results
A total of 1208 patients were recruited for EuroSC and inter-
viewed every 6 months for 2 years (n¼1024 at visit 2, n¼962 at
visit 3, n¼860 at visit 4 and n¼810 at visit 5).
3.1. Descriptive analysis
Demographic and main clinical characteristics of patients at
each visit are presented in Tables 1 and 2.
Most patients were male (62%) with a mean age of 41, and had
suffered from schizophrenia for about 14 years on average. More
than half of the sample was single when entering in the cohort.
The majority of cases (75%) were of the paranoid subtype of
schizophrenia.
The mean PANSS total score ranged between 53 and 57 over the
2 years. The PANSS negative subscore reached 15.7 and the ne-
gative factor reached 13.1. Both anxiety (PANSS G2 item) and
emotional withdrawal (PANSS N2 item) were scored on average
2.2–2.3, corresponding to an assessment between minimal and
mild, in line with the score of depression (CDSS), being on average
2.5. The functioning level was moderate (GAF: on average 52). On
average, quality of life scores (GLS) reached 4.7, and social contact
frequency scores reached 2.7.
3.2. Correlation analysis
As shown in Table 3, highly signiﬁcant correlations between
OFSC and emotional withdrawal or negative symptoms were
found. The correlations between social contact frequency and each
of the negative symptoms outcomes ranged between 0.30 and
0.20, being signiﬁcantly negative (less social contact associated
to higher severity of symptoms). The correlations between OFSC
and GAF and GLS also reached signiﬁcance, being positive (less
social contact associated to lower quality of life and functioning
level).
3.3. Multivariate models
Table 4 presents the results of the linear regressions, analysing
the change in each of the outcomes of interest between baseline
and 24 months. Independent from the outcome considered, lower
baseline social contact frequency was signiﬁcantly associated with
a deterioration of all outcomes 2 years later, except for quality of
life (p¼0.24).
Table 2
Outcomes values at each visit.
Variable Visit 1 (N¼1208) Visit 2 (N¼1024) Visit 3 (N¼962) Visit 4 (N¼860) Visit 5 (N¼810)
PANSS total score Missing values 5 185 252 351 399
Mean (SD) 57.43 (20.8) 55.73 (19.8) 55.48 (19.0) 54.07 (19.1) 53.00 (18.7)
PANSS negative subscore Missing values 3 185 251 351 398
Mean (SD) 15.78 (7.66) 15.54 (7.17) 15.46 (7.27) 15.23 (7.06) 15.06 (7.19)
PANSS negative factor Missing values 19 194 256 353 399
Mean (SD) 13.14 (6.81) 12.79 (6.44) 12.76 (6.55) 12.57 (6.33) 12.55 (6.51)
PANSS G2 item (anxiety) Missing values 4 185 254 350 399
Mean (SD) 2.34 (1.34) 2.35 (1.36) 2.26 (1.33) 2.15 (1.32) 2.06 (1.26)
PANSS N2 item (emotional withdrawal) Missing values 3 185 252 351 399
Mean (SD) 2.20 (1.31) 2.11 (1.26) 2.13 (1.30) 2.12 (1.24) 2.12 (1.28)
CDSS (depression) Missing values 3 4 7 4 0
Mean (SD) 2.87 (3.53) 2.48 (3.52) 2.37 (3.33) 2.26 (3.23) 2.08 (3.23)
GAF (functioning) Missing values 1 3 2 5 1
Mean (SD) 51.34 (16.02) 52.01 (16.36) 52.22 (15.8) 52.59 (15.59) 51.81 (16.41)
GLS (quality of life) Missing values 21 22 23 19 15
Mean (SD) 4.59 (1.33) 4.72 (1.31) 4.78 (1.29) 4.76 (1.28) 4.88 (1.25)
OFSC (objective frequency of social contact) Missing values 5 10 17 15 9
Mean (SD) 2.69 (1.02) 2.69 (1.04) 2.72 (1.04) 2.72 (1.06) 2.75 (1.06)
Table 3
Spearman correlations between OFSC and other outcomes of interest.
Outcome of interest Visit 1 (N¼1208) Pooling visits (N¼4864)
Spearman correlation Spearman correlation
PANSS N2 item (emotional
withdrawal)
0.23 (po0.0001) 0.22 (po0.0001)
PANSS negative subscore 0.28 (po0.0001) 0.27 (po0.0001)
PANSS negative factor 0.28 (po0.0001) 0.28 (po0.0001)
GAF (functioning) 0.25 (po0.0001) 0.18 (po0.0001)
GLS (quality of life) 0.09 (p¼0.0017) 0.11 (po0.0001)
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When running multivariate repeated models on the change
from the preceding visit, all the outcomes of interest were sig-
niﬁcantly related to the social contact frequency score. This is
shown in Table 5. Higher social contact frequency was signiﬁcantly
associated with a lower severity of emotional withdrawal
(po0.0001) and negative symptoms (po0.0001) and a higherTable 4
Multivariate regression models (baseline – 24 months).
N2 item (emotional withdrawal) Negative subscor
Intercept 1.574 (po0.0001) 7.863 (po0.00
Country France 0.036 (p¼0.739) 0.31 (p¼0.557
UK 0.468 (po0.0001) 1.893 (po0.00
Age 0.005 (p¼0.135) 0.02 (p¼0.245
Female 0.358 (po0.0001) 1.579 (po0.00
Baseline CDSS score 0.038 (p¼0.0008) 0.058 (p¼0.296
Baseline value 0.592 (po0.0001) 0.417 (p o0.00
Baseline OFSC score 0.132 (p¼0.0008) 0.566 (p¼0.004
Regression coefﬁcient estimate (p value).functioning level (po0.0001). A non-signiﬁcant association was
found for quality of life (p¼0.11).4. Discussion
The burden of schizophrenia is strongly related to negative
symptoms, and lack of social contact was thought to be an im-
portant element in a vicious circle, aggravating negative symp-
toms, and deteriorating psychosocial functioning and quality of
life. The purpose of the present study was to examine whether the
social contact frequency of patients with schizophrenia had an
impact on negative symptoms, both from a cross-sectional per-
spective and over time. In addition, the relationships between
social contact frequency and the health indicators psychosocial
functioning and quality of life were also explored.
Data were taken from EuroSC, a large naturalistic prognostic
cohort study carried out in UK, France and Germany. The broad
information collected, the large sample size (N¼1208) and the 24-
month follow-up encourage analyses of longitudinal associationse Negative factor GAF GLS
01) 7.633 (po0.0001) 23.591 (po0.0001) 2.946 (po0.0001)
) 0.251 (p¼0.62) 5.587 (p o0.0001) 0.027 (p¼0.807)
01) 1.429 (p¼0.001) 7.839 (po0.0001) 0.034 (p¼0.709)
) 0.013 (p¼0.442) 0.124 (p¼0.005) 0 (p¼0.944)
01) 1.526 (p o0.0001) 0.817 (p¼0.413) 0.002 (p¼0.985)
) 0.088 (p¼0.102) 0.1 (p¼0.483) 0.027 (p¼0.042)
01) 0.464 (po0.0001) 0.492 (po0.0001) 0.591 (p o0.0001)
) 0.607 (p¼0.001) 1.411 (p¼0.004) 0.047 (p¼0.24)
Table 5
Multivariate repeated regression models (each visit).
N2 item (emotional withdrawal) Negative subscore Negative factor GAF GLS
Intercept 1.127 (po0.0001) 5.021 (po0.0001) 5.013 (po0.0001) 32.983 (po0.0001) 2.516 (po0.0001)
Age 0.001 (p¼0.738) 0.01 (p¼0.164) 0.006 (p¼0.365) 0.145 (p¼0) 0.001 (p¼0.629)
Female 0.188 (po0.0001) 0.716 (po0.0001) 0.765 (po0.0001) 1.376 (p¼0.11) 0.018 (p¼0.639)
Country (France) 0.2 (po0.0001) 0.679 (p¼0.002) 0.567 (p¼0.007) 5.418 (po0.0001) 0.012 (p¼0.821)
Country (UK) 0.263 (po0.0001) 1.11 (po0.0001) 1.052 (po0.0001) 5.507 (po0.0001) 0.086 (p¼0.049)
CDSS score (preceding visit) 0.015 (p¼0.006) 0.031 (p¼0.216) 0.04 (p¼0.103) 0.34 (p¼0.011) 0.025 (p¼0.0002)
PANSS item G2 (preceding visit) 0.001 (p¼0.923) 0.04 (p¼0.564) 0.047 (p¼0.474) 0.85 (p¼0.02) 0.043 (p¼0.009)
Outcome of interest (preceding visit) 0.414 (po0.0001) 0.273 (po0.0001) 0.305 (po0.0001) 0.645 (po0.0001) 0.505 (po0.0001)
OFSC score (preceding visit) 0.069 (po0.0001) 0.277 (p¼0.001) 0.332 (po0.0001) 2.472 (po0.0001) 0.03 (p¼0.109)
Regression coefﬁcient estimate (p value).
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pected, social isolation is widespread in the study population,
having one's own family is rare, and there is little participation in
the labour market (Bebbington et al., 2005). Such a high degree of
social exclusion may be explained by the typical and quite com-
mon negative symptomatology of schizophrenia, which is an im-
portant obstacle to social inclusion; it keeps patients with schi-
zophrenia away from meaningful social interaction and simulta-
neously, from socially shared concepts of reality.
As part of the large battery of questionnaires used in the
EuroSC study, several were patient-reported outcomes (PROs),
such as the QOLI questionnaire. Despite the ongoing clinical de-
bate regarding whether or not PROs should be used in clinical
trials to assess treatment efﬁcacy, PROs in schizophrenia are
widely used.
Cross-sectional analyses were undertaken as a ﬁrst step. Re-
sults were in line with the assumptions: signiﬁcant negative cor-
relations between social contact frequency and negative symp-
toms, and signiﬁcant positive correlations between social contact
frequency and psychosocial functioning were found. In a second
step, the linear regression models added the perspective of time: a
low frequency of social contact at the baseline visit was found to
lead to higher emotional withdrawal and negative symptoms, and
lower psychosocial functioning two years later.
Comparing short term and long term effects of social contact
frequency on the indicators of negative symptoms evidence for an
ongoing process of amelioration was found, as the long term effect
is the stronger one. Results are different for psychosocial func-
tioning. The weaker long term coefﬁcient indicates a lack of con-
tinuity concerning the impact of social contact frequency on psy-
chosocial functioning. This is in line with research that found
psychosocial functioning a multiply determined outcome (Rocca
et al., 2009) with clinical factors as its main determinants (Gaite
et al., 2005).
As a non-negligible proportion of the population was lost in the
follow-up phase (20% after 12 months and 33% after 24 months), it
was important to conduct repeated measures models. Indeed,
these lost patients are usually patients with poor outcomes, and it
was likely that patients with low OFSC at the baseline were more
likely to drop out. The multivariate longitudinal perspective un-
derlined the importance of social contact as a factor in the course
of the negative symptoms side of schizophrenia. The elements of
the presumed vicious circle, negative symptoms including emo-
tional withdrawal and psychosocial functioning, were found to be
closely and signiﬁcantly related to social contact score over follow-
up time.
The meaning of low social contact frequency was simpliﬁed by
Hansen in 2009 (Hansen et al., 2009). He and other authors pro-
posed a distinction between passive social withdrawal as part of
the negative symptoms and active social avoidance related to
positive symptoms. This distinction has therapeutic implications.Passive social withdrawal with low frequency of social contact, an
issue the present study deals with, might be overcome by low
threshold offers of group therapy. A certain frequency of social
contacts would be a prerequisite of contacts that could be qualiﬁed
as friendship. In 2012, Giacco et al. evaluated which symptom
dimensions of schizophrenia are associated with the lack of
friendships (Giacco et al., 2012): a pooled analysis allowed authors
to show that higher levels of negative symptoms and hostility are
speciﬁcally associated with the lack of friendships in patients with
psychotic disorders. Here again, the bidirectional or circular
character of relations becomes evident. Interventions might focus
either on negative symptoms or on social contact, which would be
a precondition of friendship. In 2014, Jelastopulu et al. estimated
the correlation between the Personal and Social Performance (PSP)
and the PANSS in patients with schizophrenia during routine
clinical practice (Jelastopulu et al., 2014). An analysis of a long-
itudinal study with a six-month follow-up of 2010 Greek patients
revealed that the PSP score showed a high association to PANSS
score. The study underlines the close relationship between psy-
chopathology and psychosocial functioning that was demon-
strated in the present analysis.
In this analysis, only non-signiﬁcant results were found for the
relation between frequency of social contact and quality of life.
This may be due to the fact that it was not possible to include any
measure of emotional wellbeing, which might be an important
link between social contacts and quality of life, as was suggested in
a recent study (Boyer et al., 2014).
Several limitations should be acknowledged. First, the re-
presentativeness of the sample may be questioned. Indeed, as a
consequence of the inclusion and exclusion criteria, the most se-
verely ill patients are underrepresented, whereas the chronically
ill patients are overrepresented (Bebbington et al., 2005). How-
ever, EuroSC large and multinational sample size, together with
the 5-point measurements over the 2-year follow-up should be
considered a strength. In addition, the large variety of scales al-
lowed including the most important confounders in our analyses.
Second, a problem of measurement should be mentioned: there is
an overlap between the OFSC score and aspects of the negative
symptoms outcome, as one item of PANSS negative subscore and
PANSS negative factor, namely social withdrawal, a component of
negative symptoms (Puig et al., 2008), at ﬁrst glance seems to be a
measure similar to frequency of social contact. The frequency
items however ask the patient for facts only, whereas the PANSS
item “social withdrawal” relies upon different aspects of social
integration as estimated by the interviewer. His estimation will
take into account behavioural aspects of social integration inferred
from other data assessed during the interview and from patients'
social behaviour in the interview situation. Moreover, PANSS ne-
gative subscale and factor assess various aspects of non-partici-
pation in social exchange including cognitive and emotional. Al-
together, there is a clear difference between explanans and
K. Siegrist et al. / Psychiatry Research 230 (2015) 860–866 865explanandum. Third, the study is based on interviewer ratings, and
the problem of common method variance, increasing the chance of
correlations, was not avoidable. This is an unsolved problem in
social psychiatric research in schizophrenia. Nevertheless all the
scales considered in these analyses are widely approved and va-
lidated. Fourth, the reliance on self-report data of social contact
may be questioned, as PROs in schizophrenia face a major limita-
tion: psychiatric symptoms, such as hallucinations and delusions,
may impact the patient's judgment and make it unreliable. In spite
of the potential difﬁculties in obtaining outcome information from
patients with certain types of mental illness, evidence suggests
that even among those with chronic and severe mental illness,
patients are able to evaluate their condition, and the information
they provide is unique and invaluable (Schmidt et al., 2000). A
recent study has demonstrated that it is feasible to routinely col-
lect mental health outcomes data from patients with schizo-
phrenia in maintenance phase (Hunter et al., 2009). Fifth, we
postulated bi-directionality of relations, mainly between social
contact frequency and negative symptoms, yet we tested for only
one direction. The reason being the practical implications would
be the same, independent of the result. Finally, given that medi-
cation data were lacking in the large German subsample, it was
decided not to include medication parameters as a potential con-
founder in the analysis. At the time of the data collection, no
speciﬁc antipsychotic was available to treat negative symptoms.
Therefore the impact of not including medication was thought to
be limited. Nevertheless future studies should incorporate the ef-
fect of medication on level of negative symptoms.
4.1. Clinical implication
A practical implication of the ﬁndings of this study is the need
for interventions that promote the development of a stimulating
and supportive social network (Fleury et al., 2013). Reinforcing and
encouraging social contact in therapeutic groups offering psy-
chosocial and socio-emotional skills training might prove effective
in achieving less negative symptomatology, improved psychosocial
functioning and better quality of life. Suggestions for speciﬁc in-
terventions to increase social contacts are not easy to make, as per
the composite nature of the social contact measure used in this
analysis. Nevertheless any social interaction (e.g. visits, phone,
organised activity) is thought to act as a bottom–up anti-stigma
measure and to facilitate social inclusion of patients with
schizophrenia.
It would be insightful exploring the importance of social net-
work indicators for the course of the disease in more detail.
Questions to be answered by cohort studies may concern the re-
lation of social contact: their frequency, the type of contact (family,
partner, friend, neighbour, and colleague), and emotional close-
ness (i.e. friendship yes or no), with aspects of functioning and
quality of life over time. One objective of such studies would be to
ﬁnd starting points for therapeutic interventions focusing on dif-
ferent groups of patients. It is likely that not all patients would
equally proﬁt from interventions promoting social contacts.
4.2. Conclusion
Using data from a large European cohort of patients with
schizophrenia, it was shown that a lack of social contact is pre-
dictive of more severe negative symptoms, worse psychosocial
functioning and worse quality of life, both from a cross-sectional
perspective and over time. There is a need for interventions that
promote the development of a stimulating and supportive social
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